Written by Klarity Editorial Team
Published: Jun 4, 2026

You’re a psychiatric mental health nurse practitioner (PMHNP) or thinking about becoming one. You know you can manage anxiety disorders — you’ve got the training, the clinical hours, the board certification. But can you actually prescribe the medications your patients need?
Or maybe you’re a psychiatrist wondering how your scope compares to the PMHNPs you’re working alongside (or competing with) for patients.
Here’s the short answer: Yes, nurse practitioners can prescribe anxiety medications, including controlled substances like benzodiazepines — but whether you can do it independently or need a physician’s blessing depends entirely on which state you’re licensed in.
Let’s break down what that actually means for your practice in 2026.
Not all states treat PMHNPs equally. Your ability to prescribe anxiety meds falls into one of three categories:
In about half of U.S. states, PMHNPs can evaluate, diagnose, and prescribe medications — including Schedule IV benzodiazepines and other controlled substances — without any physician supervision. Your authority for treating anxiety is functionally identical to a psychiatrist’s.
Examples: New York (since 2022), Oregon, Washington, Arizona, Connecticut.
What this means: You can open your own practice, join a telehealth platform, prescribe Lexapro or Xanax as clinically appropriate, and never need a physician to co-sign or review your work. New York’s shift to full practice in 2022 was a game-changer — the state removed its 3,600-hour collaborative agreement requirement entirely, making it one of the most NP-friendly states for psychiatric care.
These states require a collaborative agreement with a physician for prescriptive authority, but you have some independence in your day-to-day practice. The physician doesn’t supervise every decision, but they’re legally tied to your prescribing ability.
Examples: California (transitioning), Illinois (with a pathway to FPA), Pennsylvania.
What this means: You need a formal written agreement with a supervising psychiatrist or physician. That physician might review a percentage of your charts, be available for consultation, or co-sign certain prescriptions (especially Schedule II controlled substances). If you want to prescribe benzodiazepines for panic disorder, it needs to be outlined in your collaborative agreement.
In Illinois, for instance, after 4,000 clinical hours and 250 hours of continuing education, you can apply for full practice authority — but even then, you need a one-time physician sign-off to prescribe benzos or Schedule II drugs. Once you have that, you’re essentially independent for anxiety management.
California is mid-transition: AB 890 created a pathway where experienced NPs (those with 3+ years and certain qualifications) can become ‘103 NPs’ and practice in group settings without physician protocols starting in 2023. By January 2026, they can apply to be ‘104 NPs’ and practice fully independently, including solo telehealth. If you’re a newer PMHNP in California, you’re still operating under physician supervision for now.
In these states, you need direct physician supervision or delegation for all prescribing — and sometimes all practice activities. The physician isn’t just a collaborator; they’re legally required to oversee your work closely.
Examples: Texas, Florida.
What this means: In Texas, you must have a Prescriptive Authority Agreement with a physician to write any prescription. The physician doesn’t co-sign every script in real time, but they review your charts regularly and must be available for consultation. Importantly, Texas bans NPs from prescribing Schedule II controlled substances (like Adderall) outside of hospital or hospice settings — though benzodiazepines (Schedule IV) are fine if your supervising physician authorizes it.
Florida requires a written protocol with a physician for all PMHNP practice. Florida NPs can prescribe controlled substances, but there’s a 7-day supply limit on Schedule II prescriptions unless you’re a psychiatric NP treating a mental health condition — in which case you can prescribe longer courses of anxiety meds like benzodiazepines. You still need that physician protocol on file, though.
Let’s get specific. Here’s how scope of practice affects what you can prescribe:
SSRIs/SNRIs (e.g., sertraline, escitalopram, venlafaxine):
These are first-line treatments for anxiety disorders. In every state, PMHNPs with prescriptive authority can prescribe these medications. Even in restricted states like Texas or Florida, these non-controlled meds are well within your scope as long as you have your collaborative agreement or protocol in place.
Benzodiazepines (e.g., alprazolam, lorazepam, clonazepam):
These Schedule IV controlled substances are where state laws start to diverge. In FPA states, you can prescribe them independently based on clinical judgment. In reduced/restricted states, you need physician authorization:
Buspirone, hydroxyzine, beta-blockers:
These non-controlled anxiolytics are prescribable in all states with NP authority. No special restrictions.
Stimulants (Schedule II, e.g., Adderall for comorbid ADHD):
This is where many states draw a harder line. In Texas, NPs cannot prescribe Schedule II drugs in outpatient settings except in hospitals or for hospice patients. In Florida, NPs are limited to 7-day supplies of Schedule II unless they’re a psychiatric NP treating a mental disorder (which covers ADHD). In FPA states like New York, PMHNPs can prescribe stimulants independently. In Pennsylvania, the physician must co-sign Schedule II prescriptions within 24 hours.
Here’s the good news: federal rules still allow you to prescribe controlled substances via telehealth without an initial in-person visit. The DEA and HHS extended COVID-era telemedicine flexibilities through December 2026, which means you can evaluate a new patient via video and initiate a benzodiazepine for panic disorder or an SSRI for generalized anxiety entirely remotely.
This was a huge relief for providers — in 2024 alone, over 7 million controlled substance prescriptions for ADHD, anxiety, and other conditions were written via telemedicine. The extension gives regulators time to finalize permanent rules (expected late 2026), which may introduce a special telemedicine DEA registration or other safeguards. For now, you’re in the clear federally.
But state rules still apply. A few state-specific notes:
Florida: State law expressly permits teleprescribing of Schedule II drugs for psychiatric disorders, which means anxiety and ADHD meds are fine via telehealth. However, if you’re an out-of-state provider with only Florida’s telehealth registration (not a full FL license), you cannot prescribe controlled substances remotely in Florida.
Texas: No state-level prohibition on telehealth prescribing of anxiety meds, but Texas does ban telemedicine treatment of chronic pain with controlled substances. Anxiety treatment doesn’t fall under that ban. You still need a valid patient-practitioner relationship established via live audio-visual exam.
California: No special telehealth restrictions beyond federal law. Psychiatrists and NPs (once they have prescriptive authority) can prescribe controlled anxiolytics via video visit.
Pennsylvania & Illinois: Both states follow federal telemedicine rules. No additional state-level barriers to prescribing anxiety meds remotely, though you must maintain your collaborative agreement (if required) and check the state PDMP.
PDMP Requirements: Nearly every state mandates checking the Prescription Drug Monitoring Program before prescribing controlled substances. New York’s is one of the strictest — you must check iSTOP for every controlled prescription. Texas, Florida, California, and Illinois all require PDMP checks as well. This is non-negotiable and applies equally to telehealth and in-person care.
Let’s be blunt: in restricted and reduced practice states, there’s a gap. Psychiatrists (MD/DO) can prescribe any anxiety medication in any state without needing a collaborative agreement, without supply limits, and without physician oversight. They have full DEA authority from day one of licensure.
PMHNPs in FPA states like New York are functionally at parity — you can do everything a psychiatrist can do for anxiety treatment, including independent prescribing of benzodiazepines and controlled substances. The only practical difference is Medicare’s payment structure (more on that in a moment) and possibly patient perception.
In states like Texas, Florida, or Pennsylvania, the gap is real:
This isn’t a knock on PMHNPs — you have the clinical training to manage anxiety disorders effectively. It’s a legislative and regulatory barrier, not a competency issue. Research shows that PMHNPs provide high-quality medication management for anxiety and depression, often with outcomes comparable to psychiatrists, especially for routine cases.
But for providers considering where to practice or which platform to join, understanding these scope differences is critical. If you’re a PMHNP in a restricted state, working for a telepsychiatry platform that handles physician collaboration for you can remove a major administrative headache.
Not quite. Medicare reimburses PMHNPs at 85% of the physician fee schedule when you bill under your own NPI. For example:
For an initial psychiatric evaluation (CPT 90792), psychiatrists get ~$202, while PMHNPs get ~$172.
Most private insurers follow Medicare’s lead, though some state Medicaid programs pay NPs at 100% of physician rates (others pay 85-90%). Platforms like Klarity typically account for this in how they structure provider compensation, but it’s something to be aware of if you’re negotiating contracts or comparing opportunities.
The slight reimbursement difference doesn’t reflect your value — it’s an outdated Medicare policy. Many states have introduced or are considering parity laws to equalize NP and physician payment, especially for mental health services where there’s a massive shortage of providers.
Yes — in all 50 states, PMHNPs with prescriptive authority can prescribe medications for anxiety disorders, including SSRIs, SNRIs, buspirone, beta-blockers, and controlled substances like benzodiazepines.
But:
If you’re practicing via telehealth, federal rules through 2026 allow you to prescribe controlled anxiety meds remotely without an in-person visit — but you still need to follow your state’s scope of practice laws and PDMP requirements.
For PMHNPs wondering whether to pursue full practice authority, move to a different state, or join a platform that handles collaboration: the rules matter. Your clinical skills are the same regardless of where you practice, but the regulatory environment determines whether you can use them to their full potential.
And if you’re a psychiatrist reading this, understanding NP scope helps you work more effectively with PMHNPs — whether you’re collaborating, supervising, or simply sharing the same patient pool on a telehealth platform. The mental health workforce shortage means we need both MDs and PMHNPs practicing at the top of their licenses.
Can a PMHNP prescribe Xanax or other benzodiazepines?
Yes, in all states where PMHNPs have prescriptive authority. In full practice states like New York, you can prescribe independently. In restricted states like Texas or Florida, you need physician authorization in your collaborative agreement or protocol, plus a DEA registration and compliance with state PDMP requirements.
What states allow PMHNPs to prescribe anxiety medications independently?
About 25-30 states grant full practice authority to NPs, including New York, Oregon, Washington, Arizona, Connecticut, Maryland, and others. In these states, PMHNPs can prescribe all anxiety medications — including controlled substances — without physician supervision.
Do I need a DEA license to prescribe anxiety medications as a PMHNP?
You need a DEA registration to prescribe controlled substances (like benzodiazepines). For non-controlled anxiety meds (SSRIs, SNRIs, buspirone), you don’t need a DEA license, just state prescriptive authority. In reduced or restricted practice states, you may need your supervising physician to sign off on your DEA application.
Can PMHNPs prescribe anxiety medications via telehealth?
Yes. Federal rules through 2026 allow telehealth prescribing of controlled substances without an initial in-person visit. State laws vary slightly — for example, Florida permits teleprescribing of psychiatric meds, and Texas allows it as long as you establish a valid patient relationship via video. Always check your state’s telehealth and PDMP requirements.
How does PMHNP prescribing authority differ from a psychiatrist’s?
Psychiatrists (MD/DO) can prescribe any anxiety medication independently in all 50 states with no supervision requirements. PMHNPs have the same authority in full practice states, but in reduced or restricted practice states, you need a collaborative agreement or physician delegation. Some states also limit NP authority for Schedule II controlled substances (like stimulants).
What’s the difference between a collaborative agreement and physician supervision?
A collaborative agreement (common in reduced practice states) means you work under a written protocol with a physician who reviews your work periodically but doesn’t oversee every decision. Physician supervision (in restricted states) means the physician must actively oversee your practice, often co-signing prescriptions or reviewing charts regularly. Both are state-specific requirements.
Can I prescribe SSRIs for anxiety as a PMHNP in Texas or Florida?
Yes. In both Texas and Florida, PMHNPs with prescriptive authority and a collaborative agreement or protocol can prescribe SSRIs, SNRIs, and other non-controlled anxiety medications without additional restrictions.
Do PMHNPs get reimbursed the same as psychiatrists for anxiety medication management?
Medicare reimburses PMHNPs at 85% of the physician fee schedule (e.g., ~$81 vs. ~$95 for a 15-minute med check). Some state Medicaid programs and private insurers pay NPs at 100%, but the 85% rule is common. Most telehealth platforms account for this in provider compensation structures.
If you’re a PMHNP in a restricted state, finding a physician collaborator and navigating prescriptive authority rules can feel like a part-time job in itself. If you’re a psychiatrist, you might be spending thousands of dollars a month on marketing just to fill your schedule with qualified patients.
Klarity Health solves both problems.
We connect psychiatrists and PMHNPs with pre-qualified patients seeking medication management for anxiety, depression, ADHD, and other psychiatric conditions. You set your availability, we handle patient acquisition, credentialing, and billing. No upfront marketing spend. No wasted ad dollars on leads that ghost you. You only pay when you see a patient.
For PMHNPs in states that require collaboration, we can help facilitate those relationships. For all providers, we handle the infrastructure — telehealth platform, scheduling, insurance billing, patient matching — so you can focus on clinical care.
Join Klarity’s provider network and start seeing patients on your terms. No marketing gambles. No empty calendar slots. Just steady patient flow and guaranteed ROI.
Explore Klarity for Providers →
The following sources were consulted to provide up-to-date information on PMHNP prescribing authority and anxiety medication regulations (all sources verified for currency as of February 26, 2026):
U.S. Department of Health and Human Services (HHS) – ‘HHS & DEA Extend Telemedicine Flexibilities Through 2026’ (Jan 2, 2026) – Official federal policy on telehealth prescribing of controlled substances. www.hhs.gov
Florida Senate Statutes – §464.012 (Nurse Practice Act) and §456.47 (Telehealth Prescribing) – State law defining PMHNP scope and controlled substance prescribing limits in Florida. www.flsenate.gov
California Board of Registered Nursing – AB 890 Implementation FAQs (Updated 2024) – Details on California’s transition to NP independent practice (103 NP and 104 NP categories). rn.ca.gov
Nurse Practitioners of New York (NPNY) – ‘NP Modernization Act Passes – Full Practice Authority Granted’ (Apr 9, 2022) – Announcement of New York’s removal of collaborative practice requirements for NPs. npny.enpnetwork.com
Texas Medical Board – FAQ on NP Prescribing of Schedule II Controlled Substances – State guidance on physician delegation limits for NPs in Texas. www.tmb.state.tx.us
Find the right provider for your needs — select your state to find expert care near you.